AllerGen names new Associate Scientific Director
Dr. Kelly McNagny, Professor of Medical Genetics and Co-Director of the Biomedical Research Centre at The University of British Columbia, has been named Associate Scientific Director of AllerGen, effective June 1, 2016, succeeding the inaugural incumbent, Dr. Dean Befus, Professor of Pulmonary Medicine, University of Alberta.
Within AllerGen, Dr. McNagny is Research Co-leader of the Biomarkers and Bioinformatics Enabling Platform.
“As a long-time investigator, research leader, member of the Network’s Research Management Committee, and former AllerGen Board member, Dr. McNagny has the deep corporate knowledge and understanding of the NCE program, and of AllerGen’s strategic priorities, plans, policies and processes, required for this role,” comments AllerGen’s Scientific Director Dr. Judah Denburg.
“I am truly honoured by this appointment,” says Dr. McNagny. “The AllerGen network has had a transformational effect on my career; I am only too happy to play a part in its leadership and the achievement of its strategic goals”
The Associate Scientific Director position was created to ensure continuity and minimize disruption in the leadership and management of the Network in exigent circumstances.